Khaw, PT;
Bouremel, Y;
Brocchini, S;
Henein, C;
(2020)
The control of conjunctival fibrosis as a paradigm for the prevention of ocular fibrosis-related blindness. "Fibrosis has many friends".
Eye
, 34
pp. 2163-2174.
10.1038/s41433-020-1031-9.
Preview |
Text
Bouremel_The control of conjunctival fibrosis as a paradigm for the prevention of ocular fibrosis related blindness - FINAL uploaded.pdf - Accepted Version Download (1MB) | Preview |
Abstract
The processes involved in ocular fibrosis after disease or ocular tissue injury, including surgery play an important part in the development or failure of treatment of most blinding diseases. Ocular fibrosis is one of the biggest areas of unmet need in ophthalmology. Effective anti-scarring therapies could potentially revolutionise the management of many diseases like glaucoma worldwide. The response of a quiescent or activated conjunctiva to glaucoma surgery and aqueous flow with different stimulatory components and the response to different interventions and future therapeutics is a paradigm for scarring prevention in other parts of the eye and orbit. Evolution in our understanding of molecular and cellular mechanisms in ocular fibrosis is leading to the introduction of new and re-purposed therapeutic agents, targeting a wide range of key processes. This review provides current and futures perspectives on different approaches to conjunctival fibrosis following glaucoma surgery and highlights the challenges faced in implementing these therapies with maximal effect and minimal side effects.
Archive Staff Only
 |
View Item |
